Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
COATS LONNEL
Chief Executive Officer at LEXICON PHARMACEUTICALS. Filing since 15 Sep 2017.
CIK 0001612528
Company
Date
Role
Action
Shares
Amount
Of holding
LXRX
LEXICON PHARMACEUTICALS, INC.
16 Nov 2023
Chief Executive Officer
Bought
90,000
$94.80K
10.9%
LXRX
LEXICON PHARMACEUTICALS, INC.
10 Nov 2023
Chief Executive Officer
Bought
10,000
$10.10K
1.2%
LXRX
LEXICON PHARMACEUTICALS, INC.
29 Jun 2023
Chief Executive Officer
Bought
10,000
$21.60K
1.2%
LXRX
LEXICON PHARMACEUTICALS, INC.
26 Jun 2023
Chief Executive Officer
Bought
10,000
$21.79K
1.3%
LXRX
LEXICON PHARMACEUTICALS, INC.
23 Jun 2023
Chief Executive Officer
Bought
10,000
$24.95K
1.3%
LXRX
LEXICON PHARMACEUTICALS, INC.
22 Jun 2023
Chief Executive Officer
Bought
40,000
$92.40K
5.4%
LXRX
LEXICON PHARMACEUTICALS, INC.
18 Sep 2019
President and CEO
Bought
50,000
$155.00K
28.2%
LXRX
LEXICON PHARMACEUTICALS, INC.
17 Sep 2019
President and CEO
Bought
50,000
$156.40K
39.2%
LXRX
LEXICON PHARMACEUTICALS, INC.
19 Aug 2019
President and CEO
Bought
3,000
$4.19K
2.4%
LXRX
LEXICON PHARMACEUTICALS, INC.
16 Aug 2019
President and CEO
Bought
37,000
$49.83K
42.3%
LXRX
LEXICON PHARMACEUTICALS, INC.
15 Nov 2017
President and CEO
Bought
10,000
$99.10K
30.3%
LXRX
LEXICON PHARMACEUTICALS, INC.
15 Sep 2017
President and CEO
Bought
30,000
$376.34K
×10
12 decisions on file.